Connect with us

Health

Health care costs up to 300% higher for privately insured patients than those with Medicare, report reveals

Published

on

Health care costs up to 300% higher for privately insured patients than those with Medicare, report reveals

Most Americans — more than 65% — have private health insurance, but a new report has revealed a potentially very expensive drawback.

Patients who have private (commercial) coverage may end up paying significantly more for their medical care compared to those who have public health insurance, such as Medicare, according to recent data from RAND Corp. in Washington, D.C.

As of 2022, employers and private insurance companies paid an average of 254% more for medical services than what Medicare programs would have paid.

HEALTH CARE COSTS UP TO 300% HIGHER FOR PRIVATELY INSURED PATIENTS THAN THOSE WITH MEDICARE

Several states — California, Florida, Georgia, New York, South Carolina, West Virginia, and Wisconsin — had medical costs that were more than 300% higher than Medicare prices, the report stated.

Advertisement

The researchers analyzed medical claims data from a “large population” of privately insured patients who were treated at over 4,000 hospitals across the country between 2020 and 2022.

Patients who have private coverage may end up paying significantly more for their medical care compared to those who have public health insurance, such as Medicare. (iStock)

The report also included the names and prices of each hospital.

“Calculating 4,000-plus U.S. hospitals’ overall relative prices has never been done before this study, because it’s so difficult to collect the requisite data and to get permissions to publish the hospital and health system names associated with each relative price,” said Brian Briscombe, a health care analyst at RAND and one of the study authors, to Fox News Digital.

AS CHOLERA CASES RISE WORLDWIDE, HEALTH OFFICIALS SOUND ‘CONCERNING’ ALARM ABOUT VACCINE SHORTAGES

Advertisement

“This is real price transparency — naming the hospitals and presenting their overall relative prices in a way that anyone could understand.”

The report gives employers a tool they can use to become “better-informed purchasers” of health care services, Peter Hussey, director of RAND Health Care in Santa Monica, California, noted in a news release. 

“Hospitals account for the largest share of health care spending in the U.S., so this report also provides valuable information that may aid policymakers interested in curbing health care costs,” Hussey also said in the release.

The researchers analyzed medical claims data from a “large population” of privately insured patients who were treated at more than 4,000 hospitals across the country between 2020 and 2022. (iStock)

The wide variance of prices across hospitals is the most important takeaway, according to Briscombe.

Advertisement

“Within a single city, you can find a hospital that (on average across all its services) charges privately insured patients about twice as much as Medicare charges for those same services — but down the street, another hospital charges three times what Medicare charges,” he told Fox News Digital. 

The difference in prices cannot be explained by differences in quality, he added.

“This is real price transparency — naming the hospitals and presenting their overall relative prices in a way that anyone could understand.”

Dr. Brett Osborn, a Florida neurologist and longevity expert, was not involved in the RAND study but said the findings are “concerning.”

“Hospitals bill private insurers multiples of the Medicare allowable,” he told Fox News Digital.

Advertisement

“The elevated costs are passed onto patients, resulting in higher premiums and out-of-pocket expenses.”

As of 2022, employers and private insurance companies paid an average of 254% more for medical services than what Medicare programs would have paid, according to a new study.  (iStock)

And these costs are on the rise, Osborn warned. 

“People accept job offers because the employer offers health insurance — otherwise, for many, the premiums would be unaffordable,” he added.

Osborn emphasized the significant price variations among states.

Advertisement

SOME PATIENTS WHO SEE FEMALE DOCTORS COULD LIVE LONGER, STUDY SUGGESTS: ‘HIGHER EMPATHY’

“Hospitals in some states charge less than 200% of Medicare rates, while others exceed 300%,” he said.  

“Due to its size, Medicare can negotiate lower payments — but private insurers lack this leverage.”

“This discrepancy is due to some hospitals’ market power, making it hard for employers to avoid them. Due to its size, Medicare can negotiate lower payments — but private insurers lack this leverage.”

The doctor also called for greater price transparency from hospitals.

Advertisement

The new report published the names and pricing models of more than 4,000 U.S. hospitals. (iStock)

“Despite a federal rule for price transparency, only 24.5% of hospitals comply — highlighting the need for informed health care purchasing and policy changes to manage costs,” he said. 

“The system is fundamentally flawed, designed to profit from illness rather than promote health,” Osborn continued. 

“It clearly favors hospital systems, not the patients, reinforcing the harsh reality: There is money in the sick.”

HEALTH CARE IS ‘OVERWHELMINGLY COMPLEX’ FOR OLDER ADULTS, EXPERTS SAY: ‘EVER-INCREASING HURDLE’

Advertisement

Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and a Fox News medical contributor, said the issue of price variations is complex.

“Sometimes these are hidden costs, and sometimes hospitals and other health organizations know they can get away with charging private insurers more while obscuring prices from both the insurer and the patient to help compensate for the shrinking reimbursements from public insurances,” Siegel told Fox News Digital. 

“At the same time, more out-of-pocket costs are transferred to the consumer in terms of copays and deductibles, as middlemen take the profits.”

“The system is fundamentally flawed, designed to profit from illness rather than promote health.”

With the lack of price transparency, there is no way to introduce competition, Siegel said, as the true costs and prices are hidden. 

Advertisement

The study did have some limitations, the researchers acknowledged. 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“We didn’t have sufficient claims data to publish all U.S. hospitals’ relative prices,” Briscombe told Fox News Digital. 

“Some states in the U.S. don’t have All Payor Claims Databases (APCDs), so we have to collect claims from one data contributor at a time – usually from employers that operate in that location and whose employees and dependents use those hospitals.”

“Despite a federal rule for price transparency, only 24.5% of hospitals comply, highlighting the need for informed health care purchasing and policy changes to manage costs,” according to a doctor who spoke with Fox News Digital. (iStock)

Advertisement

Overall, he said, the researchers had a “sufficiently large sample of data” to estimate the overall relative price of each hospital and health system included in the report, Briscombe said, “but it would be nice to have even more claims data in order to publish the relative prices for all U.S. hospitals.”

Fox News Digital reached out to the Centers for Medicare & Medicaid Services and the American Hospital Association requesting comment.

For more Health articles, visit www.foxnews.com/health.

Advertisement

Health

176 Lbs—Gone! Why One Woman’s Gentle Weight-Loss Tips Really Work

Published

on

176 Lbs—Gone! Why One Woman’s Gentle Weight-Loss Tips Really Work


Advertisement




Cheri’s Gentle Weight-Loss Approach Helped Her Lose Big | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Brain aging may accelerate after cancer treatment, study suggests

Published

on

Brain aging may accelerate after cancer treatment, study suggests

NEWYou can now listen to Fox News articles!

Surviving cancer as a child or young adult may have a lasting impact on aging, new research suggests.

Researchers at the University of Rochester Medical Center looked at whether life-saving treatments, like chemotherapy and radiation, could speed up biological aging.

They also aimed to determine whether this age acceleration was linked to cognitive issues related to memory, focus and learning.

The team analyzed blood samples from a group of 1,400 long-term survivors treated at St. Jude Children’s Research Hospital, using epigenetic clocks — tools that estimate biological age by examining chemical tags on DNA.

Advertisement

Biological age is determined based on damage the cells accumulate over time, versus chronological age, which is measured by how long someone has been alive, according to scientists.

Biological age is determined based on the damage cells accumulate over time, according to scientists. (iStock)

“These well-established aging-related biomarkers have previously been associated with neurocognitive impairment and decline in older non-cancer populations, particularly in cognitive domains related to aging and dementia, such as memory, attention and executive function,” the study stated.

Most of the group consisted of acute lymphoblastic leukemia survivors, or Hodgkin lymphoma survivors. Participants were at least five years past their treatment, though some had survived for several decades.

They underwent neurocognitive testing to measure their attention span, memory and information processing speed.

Advertisement

CREATIVE HOBBIES KEEP THE BRAIN YOUNG, STUDY FINDS — HERE ARE THE BEST ONES TO PURSUE

Chemotherapy was found to have the greatest impact on aging acceleration. The study suggests the treatment can alter DNA structure and cause cellular damage.

CLICK HERE FOR MORE HEALTH STORIES

“It’s no surprise to find out that young people with cancer who have chemo early in life are affected in terms of long-term aging,” Dr. Marc Siegel, senior medical analyst for Fox News, told Fox News Digital.

Participants underwent neurocognitive testing to measure their attention span, memory and speed of information processing. (iStock)

Advertisement

Researchers also found that cellular aging was closely linked to cognitive performance, as survivors of a higher biological age had more difficulty with memory and attention.

“Chemo poisons and damages cellular function — hopefully the cancer cells more than normal cells, but there is a significant impact on normal cells as well,” said Siegel, who was not involved in the study.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“There is also something called ‘chemo brain,’ which causes at least temporary difficulty with memory, concentration, word finding and brain fog,” the doctor added.

The research team hopes to use these findings to focus on intervention efforts, specifically by determining when accelerated aging begins.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Young cancer survivors have many more decades of life to live,” lead study author AnnaLynn Williams, PhD, said in a press release. “If these accelerated aging changes are occurring early on and setting them on a different trajectory, the goal is to intervene to not only increase their lifespan, but improve their quality of life.”

The team hopes this research will help in the development of early intervention tools that aim to prevent cognitive decline. (iStock)

There were some limitations to the study. The researchers could not adjust for chronic health conditions or education because they are directly impacted by treatment.

Additionally, the study only looked at the survivors at a single point of time, so it could not directly prove causation.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The study was published in the journal Nature Communications.

Fox News Digital reached out to the researchers for comment.

Related Article

4 anti-aging approaches revealed in 2025 that may help Americans live longer
Continue Reading

Health

GLP-1 Drugs Linked to Osteoporosis and Gout: Here’s How To Stay Safe

Published

on

GLP-1 Drugs Linked to Osteoporosis and Gout: Here’s How To Stay Safe


Advertisement




GLP-1 Drugs Linked To Increased Risk of Osteoporosis and Gout | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending